# Magnetic Seizure Therapy for Schizophrenia

> **NCT02746965** · NA · TERMINATED · sponsor: **Shanghai Mental Health Center** · enrollment: 79 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DEVICE:** Magpro X100 + Option
- **DEVICE:** ThymatronSystem Ⅳ Electroconvulsive System
- **OTHER:** treatment as usual (TAU)

## Key facts

- **NCT ID:** NCT02746965
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-03-01
- **Primary completion:** 2018-07-30
- **Final completion:** 2018-07-30
- **Target enrollment:** 79 (ACTUAL)
- **Why stopped:** Problems of the MST device
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02746965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02746965, "Magnetic Seizure Therapy for Schizophrenia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02746965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*